Two counts of misconduct

The Office of Research Integrity announces two new findings of research misconduct

Written byHannah Waters and Bob Grant
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Sabotaging studentsThe United States Office of Research Integrity (ORI) found former University of Michigan postdoc Vipul Bhrigu guilty of research misconduct for altering experiments and thus the data record, according to a linkurl:report;http://edocket.access.gpo.gov/2011/2011-10150.htm published yesterday (April 27) in the Federal Register."We are very happy that the ORI has been able to come to this conclusion," linkurl:Theo Ross,;http://www.sitemaker.umich.edu/rosslab/home Bhrigu's former PI, of the University of Michigan told The Scientist in an email. "Ecstatic may be a better word."
Image: Wikimedia commons
Last year, one of Ross's graduate students, Heather Ames, noticed that she kept making the same mistakes while performing experiments, and that as she corrected these errors, new ones would pop up. She grew suspicious, especially after successfully running her experiments in her boyfriend's lab, and accused postdoc Bhrigu of intentionally manipulating her experiments, including switching the labels on cell cultures, adding alcohol to her culture media, and tampering with materials related to western blots. Bhrigu was eventually caught on tape bringing a bottle of alcohol to the fridge where her media was kept. Upon seeing the video, Bhrigu confessed.In June 2010, Bhrigu pled guilty to misdemeanor charges for malicious destruction of property in district court, landing him 6 months of probation and nearly $10,000 of initial fines and costs. And now the ORI has concluded the actions also constitute research misconduct, and have banned Bhrigu from contracting or subcontracting with any US government agency or serving in an advisory capacity to the US Public Health Service. While the statement from ORI notes that he "knowingly and intentionally tampered with research materials," normally cases in which research materials are destroyed or otherwise "sabotaged" are considered destruction of property, wrote ORI spokesperson Ann Bradley in an email. But because the materials were in his own lab, and because his actions effectively altered the experimental results, this case falls under ORI's jurisdiction, she wrote. "The case is unlike any that [ORI senior staff] have seen," Bradley said. --Hannah WatersCopycat imagesThe ORI also announced another linkurl:finding;http://edocket.access.gpo.gov/2011/2011-10157.htm of research misconduct yesterday -- that of Junghee Shin, who was a PhD student in the laboratory of linkurl:Felipe Cabello;http://www.nymc.edu/People/Felipe.C.Cabello/index.html at New York Medical College. The agency concluded that Shin engaged in misconduct when she altered microscopic immunofluorescence images in papers she submitted for publication after graduating from the institution. According to an emailed statement from Donna Moriarty, a college spokesperson, a "reviewer raised questions about the data" submitted by Shin for publication. The paper, which reported studies of an immunogenic lipoprotein made by the bacterium that causes Lyme disease, was submitted to Infection and Immunity but never published. Another of Shin's papers containing manipulated figures, however, was linkurl:published;http://iai.asm.org/cgi/content/full/72/4/2280 in an April 2004 issue of Infection and Immunity. It was later linkurl:retracted;http://iai.asm.org/cgi/content/full/76/10/4792 in October 2008 after the questions arose regarding the new manuscript. "We have found that the results presented in Fig. 5 cannot be verified in the data record," the authors wrote in the retraction. The figure illustrated the results of immunofluorescence experiments that provided evidence for the partial exposure of an immunodominant protein on the surface of Lyme disease bacteria. It seems that Shin had copied and pasted images of cells staining positive for the same protein. By the time the paper was pulled from the record, however, another study had documented similar results, confirming the retracted paper's conclusions. Because Shin's work was funded by R01 National Institutes of Health, ORI conducted its own investigation, finding Shin guilty of research misconduct and requiring Shin to be closely supervised when participating in government-funded research for the next 3 years.--Bob GrantCorrection: This story has been updated from its original version to correctly state that it was not Ames herself who caught Bhrigu on videotape. The Scientist regrets the error.
**__Related stories:__*** linkurl:Opinion: Broadcasting misconduct;http://www.the-scientist.com/news/display/58086/
[23rd March 2011]*linkurl:Misconduct and adventure;http://www.the-scientist.com/news/display/57993/
[17th February 2011]*linkurl:10 retractions and counting;http://www.the-scientist.com/blog/display/57449/
[26th May 2010]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • The Scientist Placeholder Image
    This person does not yet have a bio.View Full Profile
  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform